Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021

SELL
$20.71 - $51.02 $4.46 Million - $11 Million
-215,380 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$21.84 - $44.0 $2.95 Million - $5.94 Million
135,000 Added 167.95%
215,380 $7.89 Million
Q3 2020

Nov 13, 2020

BUY
$13.63 - $24.12 $1.1 Million - $1.94 Million
80,380 New
80,380 $1.74 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $165M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.